ConductScience.org, home

Paper36849331

Elexacaftor/tezacaftor/ivacaftor projected survival and long-term health outcomes in people with cystic fibrosis homozygous for F508del.

Lopez A and 4 others. J Cyst Fibros, 2023. Cited by 126 papers, by iCite.

Cite this record

ConductScience Library. Elexacaftor/tezacaftor/ivacaftor projected survival and long-term health outcomes in people with cystic fibrosis homozygous for F508del. Papers, record 36849331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36849331

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Elexacaftor/tezacaftor/ivacaftor projected survival and long-term health outcomes in people with cystic fibrosis homozygous for F508del.
PubMed
Journal
J Cyst Fibros
PubMed
Year
2023
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
126
iCite
Relative citation ratio, by iCite
17.3
iCite
Revised in PubMed
2026-01-27
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Lopez AAndrea
2Daly CConor
3Vega-Hernandez GGabriela
4MacGregor GGordon
5Rubin JLJaime L

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Cystic FibrosisMajor topic
Humans
Child
Adolescent
Cystic Fibrosis Transmembrane Conductance Regulator
Aminophenols
Benzodioxoles
Treatment Outcome
Mutation
Chloride Channel Agonists
Pyrazoles
Pyridines
Pyrrolidines
Quinolones
Indoles

Source PubMed

Download CSV of topics

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in37357035Median age of survival in the 80s! Is there sufficient evidence to believe it?https://conductscience.org/library/papers/37357035

Source PubMed

Download CSV of comments and corrections

Cited by68

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 126 citations.

PMIDTitleJournalYearIn PapersSource
42790887The New Landscape of Cystic Fibrosis in the Era of Highly Effective Cystic Fibrosis Transmembrane Conductance Regulator Modulator Therapy.J Mother Child2026https://conductscience.org/library/papers/42790887PubMed
42774065Case report end-stage cystic fibrosis with fatal outcome in two siblings from a Chinese family: a 15-year diagnostic odyssey.Front Pharmacol2026https://conductscience.org/library/papers/42774065PubMed
42724683Treatment with CFTR modulators and subsequent remission of AA amyloidosis.Clin Kidney J2026https://conductscience.org/library/papers/42724683PubMed
42509903Evolving Cystic Fibrosis Therapy: The Good, the Sad, and the Hopeful.Children (Basel)2026https://conductscience.org/library/papers/42509903PubMed
42439510Effects of elexacaftor/tezacaftor/ivacaftor on the nasal microbial metagenome in cystic fibrosis.Microbiol Spectr2026https://conductscience.org/library/papers/42439510PubMed
42435399Residual disease activity in cystic fibrosis lung disease: implications for clinical management and research.Am J Respir Crit Care Med2026https://conductscience.org/library/papers/42435399PubMed
42218569Remodelling of cystic fibrosis respiratory microbiota in response to extended elexacaftor-tezacaftor-ivacaftor therapy.Microbiome2026https://conductscience.org/library/papers/42218569PubMed
42107694Effectiveness of Cystic Fibrosis Transmembrane Conductance Regulator Modulator Therapy on Risk of Death for Individuals With Cystic Fibrosis.Chest2026https://conductscience.org/library/papers/42107694PubMed
41951869Cystic fibrosis care today-a narrative review based on views of experts, patients and the public.Wien Klin Wochenschr2026https://conductscience.org/library/papers/41951869PubMed
41895691Updates in Cystic Fibrosis Bone Disease in Adults.Endocr Pract2026https://conductscience.org/library/papers/41895691PubMed
41878283ENHANCE: a community partnership charting the evolution of early-life cystic fibrosis disease manifestations in a new era of management.ERJ Open Res2026https://conductscience.org/library/papers/41878283PubMed
41878276Tracking early cystic fibrosis in the new era.ERJ Open Res2026https://conductscience.org/library/papers/41878276PubMed
41739723Estimation of care costs for individuals with cystic fibrosis at a referral center: cohort study, Salvador, 2005-2022.Epidemiol Serv Saude2026https://conductscience.org/library/papers/41739723PubMed
41715083Prioritising cardiopulmonary exercise testing for adults with cystic fibrosis: a service evaluation.BMC Pulm Med2026https://conductscience.org/library/papers/41715083PubMed
41588096The evolving understanding of cystic fibrosis-related diabetes in the highly effective modulator therapy era: a scoping review.Diabetologia2026https://conductscience.org/library/papers/41588096PubMed
41587811Social determinants of health, cystic fibrosis-related diabetes, and mental health in adult patients with cystic fibrosis: a critical synthesis of narrative review.Ther Adv Respir Dis2026https://conductscience.org/library/papers/41587811PubMed
41587390Exploring Exercise as Airway Clearance in Cystic Fibrosis: A Qualitative Study From the ExACT-CF Feasibility Trial.Pediatr Pulmonol2026https://conductscience.org/library/papers/41587390PubMed
41238903Effectiveness of elexacaftor/tezacaftor/ivacaftor therapy in children and adolescents with cystic fibrosis and normal spirometry.Pediatr Res2026https://conductscience.org/library/papers/41238903PubMed
41209022Cutaneous and Ocular Rosacea Associated with Elexacaftor, Tezacaftor and Ivacaftor, A Treatment for Cystic Fibrosis: A Case Report.J Pediatr Clin Pract2025https://conductscience.org/library/papers/41209022PubMed
41198444Functional CFTR may be required for Prevotella melaninogenica regulation of epithelial cell defense against Staphylococcus aureus.J Cyst Fibros2026https://conductscience.org/library/papers/41198444PubMed

See all 68 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
CFTR1080PubTator's text mininghttps://conductscience.org/library/genes/1080

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36849331

GET https://conductscience.org/api/papers/v1/36849331/cited_by?page=2